TTF1's role in lung pathology and differential diagnosis is well documented because it primarily exists in enhanced surface-active substances and Clara cell secretory protein region binding sites that can maintain lung cancer cell activity [29], but its prognostic value, particularly for patients with advanced-stage lung cancer with an EGFR genetic mutation, has received less attention. The gene discussed is EGFR; the disease is lung carcinoma.